See also this year's filing and all EDGAR filings for this company.
PDF Report 0001610820_2026_Briacell_Therapeutics_Corp.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001610820, Briacell Therapeutics Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 19,926,576 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 184,525 |
| 2 | PropertyPlantAndEquipmentNet | 296,819 |
| 3 | remainder_Assets | 1,241,786 |
| 4 | LiabilitiesCurrent | 3,977,988 |
| 5 | LiabilitiesNoncurrent | 337,672 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,934,125 |
| 9 | ResearchAndDevelopmentExpense | 21,270,678 |
| 10 | remainder_Expenses | -758,364 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -109,701 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 21,649,706 |
| 1 | Liabilities | 4,315,660 |
| 2 | Expenses | 26,446,439 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 17,334,046 |
| 5 | NetIncome | -26,556,140 |
| 6 | ComprehensiveNetIncome | -26,556,140 |
| 7 | BaseVar | 26,260,753 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.865 |
| 9 | EconomicCapitalRatio | 2.19 |